The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges

By S. Cosgrove, Youlin Qi, K. Kaye, S. Harbarth, A. Karchmer, Yehuda Carmeli. Infection Control & Hospital Epidemiology, 2005

994 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/5fa3e3ca3c05ad218f86e42ce1adc1636bc5bcae

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Emily R. M. Sydnor
2. Trish Perl
3. R. M. Klevens
4. M. Morrison
5. J. Boyce
6. R. Gordon
7. F. Lowy
8. S. Ray

Citations in the corpus

• Invasive methicillin-resistant Staphylococcus aureus infections in the United States. (2007, background): “In the hospital, MRSA infections are associated with greater lengths of stay, higher mortality,(22) and increased costs.(23,24) Although more recently there has been increased surveillance activity for invasive MRSA infections in the community, surveillance for MRSA bloodstream infections in the Uni”
• SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus (2003, result): “compared patients with MRSA bloodstream infection with those with MSSA bloodstream infection in multivariate analyses; those with MRSA bloodstream infection had increased lengths of hospital stay and hospital charges.(16) They concluded that MRSA bloodstream infections resulted in an estimated incre”
• Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005 (2007, unknown): “Estimates of the excess cost of an infection with MRSA compared with an infection with methicillin-sensitive S . aureus range from ≈ $3,000 to $35,000 ( 31 – 33 ).”
• The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. (2006, unknown): “in 2 recently published cohort studies [19, 20].”
• Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. (2010, unknown): “[ 18 ]”
• Pathogenesis of methicillin-resistant Staphylococcus aureus infection. (2008, background): “Other studies did not demonstrate increased mortality associated with nosocomial MRSA bacteremia [104] or ventilator-associated pneumonia [105], compared with MSSA infections.”
• Hospital Epidemiology and Infection Control in Acute-Care Settings (2011, background): “MSSA and MRSA are normally found colonizing the nares and skin of healthy humans (250, 292).”